U.S. market Closed. Opens in 7 hours 34 minutes

INMB | INmune Bio, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue155.00K374.00K181.00K10.92K77.69MN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit155.00K374.00K181.00K10.92K77.69MN/AN/AN/A
Operating Expenses29.90M26.32M29.33M12.24M9.30M12.44M981.48KN/A
Selling, General & Admin9.62M9.26M8.79M6.32M6.02M11.33M546.12K126.00K
Research & Development20.27M17.07M20.54M5.92M3.28M1.11M435.36K101.50K
Other Operating Expenses-267.00K-1.35M-1.19M128.52KN/AN/AN/AN/A
Operating Income-29.74M-25.95M-29.15M-12.23M-7.76M-12.44M-981.48K-227.49K
Other Expenses / Income-267.00K-1.35M-1.19M128.52K77.69KN/A149.99K-50.00K
Before Tax Income-30.01M-27.30M-30.34M-12.10M-7.68M-12.44M-831.49K-277.49K
Income Tax Expenses-29.74M1.35M-29.15M-12.23M1.46MN/AN/AN/A
Net Income-30.01M-28.65M-30.34M-12.10M-9.14M-12.44M-831.49K-277.49K
Interest ExpensesN/A1.35MN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding17.98M17.93M16.13M11.99M10.27M11.22M11.22M11.22M
Diluted Shares Outstanding17.98M17.93M16.13M11.99M10.27M11.22M11.22M11.22M
EBITDA-29.74M-25.95M-29.15M-12.23M-10.84M-12.44M-831.49K-177.49K
EBITDA Margin-19,187.74%-6,938.77%-16,106.63%-112,016.09%-13.95%0.00%0.00%0.00%
EBIT-59.75M-25.95M-59.49M-24.33M-7.68M-12.44M-831.49K-277.49K
EBIT Margin-38,547.74%-6,938.77%-32,869.06%-222,857.81%-9.88%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙